CTLA-4 is a second receptor for the B cell activation antigen B7.

Cited by (1,000)

Items 101–200 of 1,000

1. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
   EC Guinan, John G. Gribben, VA Boussiotis, GJ Freeman, Lee Marshall Nadler · 1994 · Blood
2. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
   Marek Z. Kubin, Malek Kamoun, Giorgio Trinchieri · 1994 · The Journal of Experimental Medicine
3. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
   Gordon James Freeman, Frank Borriello, Richard J. Hodes, Hans Reiser, John G. Gribben, J W Ng, J Kim, J M Goldberg, Karen S. Hathcock, Glória László · 1993 · The Journal of Experimental Medicine
4. Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
   Monica Marzagalli, Nancy D. Ebelt, Edwin Ramos Manuel · 2019 · Seminars in Cancer Biology
5. Tyrosine Phosphorylation Controls Internalization of CTLA-4 by Regulating Its Interaction with Clathrin-Associated Adaptor Complex AP-2
   Tooru Shiratori, Shoichiro Miyatake, Hiroshi Ohno, Chiaki Nakaseko, Kaichi Isono, Juan S. Bonifacino, Takashi Saito · 1997 · Immunity
6. Resistance of Crohn’s Disease T Cells to Multiple Apoptotic Signals Is Associated with a Bcl-2/Bax Mucosal Imbalance
   Kenji Ina, Jugoh Itoh, Kouhei Fukushima, Kazuo Kusugami, Takeo Yamaguchi, Kazuhiro Kyokane, Akira Imada, David G. Binion, Alessandro Musso, Gail A. West et al. · 1999 · The Journal of Immunology
7. Differential Regulation of Murine T Lymphocyte Subsets
   Frank W. Fitch, Maureen D. McKisic, D W Lancki, Thomas Frank Gajewski · 1993 · Annual Review of Immunology
8. CTLA-4 blockade in tumor models: an overview of preclinical and translational research.
   Joseph F. Grosso, Maria Jure‐Kunkel · 2013 · Europe PMC (PubMed Central)
9. The B7 Family and Cancer Therapy: Costimulation and Coinhibition
   Xingxing Zang, James Patrick Allison · 2007 · Clinical Cancer Research
10. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells.
    Michael P. Cooke, Andrew William Heath, Kevan M. Shokat, Y Zeng, Fred D. Finkelman, Peter S. Linsley, M Howard, Christopher Carl Goodnow · 1994 · The Journal of Experimental Medicine
11. Corynebacterium pseudotuberculosis and its Role in Ovine Caseous Lymphadenitis
    Graham J. Baird, M.C. Fontaine · 2007 · Journal of Comparative Pathology
12. CTLA4 mediates antigen-specific apoptosis of human T cells.
    John G. Gribben, Gordon James Freeman, Vassiliki A. Boussiotis, Paul D. Rennert, C L Jellis, Edward A. Greenfield, Melissa A. Barber, Vincent A. Restivo, Xiao-Yen Ke, G S Gray · 1995 · Proceedings of the National Academy of Sciences
13. Blockade of T Lymphocyte Costimulation with Cytotoxic T Lymphocyte–Associated Antigen 4–Immunoglobulin (Ctla4ig) Reverses the Cellular Pathology of Psoriatic Plaques, Including the Activation of Keratinocytes, Dendritic Cells, and Endothelial Cells
    Judith R. Abrams, Susan L. Kelley, Elizabeth Hayes, Toyoko Kikuchi, Michael J. C. Brown, Sewon Kang, Mark Lebwohl, Cynthia A. Guzzo, Brian V. Jegasothy, Peter S. Linsley et al. · 2000 · The Journal of Experimental Medicine
14. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.
    Masayuki Amagai, Takashi Hashimoto, Nobutaka Shimizu, Takeji Nishikawa · 1994 · Journal of Clinical Investigation
15. CD28-B7 interactions in T-cell activation
    James Patrick Allison · 1994 · Current Opinion in Immunology
16. CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
    Navid Sobhani, Dana Rae Tardiel-Cyril, Aram Davtyan, Daniele Generali, Raheleh Roudi, Yong Li · 2021 · Cancers
17. T cell anergy and costimulation
    Leonard Joseph Appleman, Vassiliki A. Boussiotis · 2003 · Immunological Reviews
18. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines.
    Frank Oliver Nestle, Laurence A. Turka, Brian J. Nickoloff · 1994 · Journal of Clinical Investigation
19. IL‐2 gene expression and NF‐kappa B activation through CD28 requires reactive oxygen production by 5‐lipoxygenase.
    Marek Łoś, Heike Schenk, Klaus Hexel, Patrick A. Baeuerle, Wulf Dröge, Klaus Schulze‐Osthoff · 1995 · The EMBO Journal
20. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.
    Christian P. Larsen, Shannon C. Ritchie, Thomas C. Pearson, Peter S. Linsley, Robin P. Lowry · 1992 · The Journal of Experimental Medicine
21. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.
    Ulrike Utans, Robert John Arceci, Y Yamashita, Mary E. Russell · 1995 · Journal of Clinical Investigation
22. Cancer and the Immune System: Basic Concepts and Targets for Intervention
    Drew M. Pardoll · 2015 · Seminars in Oncology
23. CTLA-4: From mechanism to autoimmune therapy
    Arezoo Hosseini, Tohid Gharibi, Faroogh Marofi, Zohreh Babaloo, Behzad Baradaran · 2020 · International Immunopharmacology
24. Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies
    Ryan Joseph Sullivan, Jeffrey S. Weber · 2021 · Nature Reviews Drug Discovery
25. A snapshot of the PD-1/PD-L1 pathway
    Chinmoy Ghosh, Gary Luong, Yue Sun · 2021 · Journal of Cancer
26. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.
    William Ho, Michael P. Cooke, Christopher Carl Goodnow, Mark M. Davis · 1994 · The Journal of Experimental Medicine
27. What's the difference between CD80 and CD86?
    David Michael Sansom, Claire N. Manzotti, Yong Zheng · 2003 · Trends in Immunology
28. Human and porcine early kidney precursors as a new source for transplantation
    Benjamin Dekel, Tatyana Burakova, Fabian David Arditti, Shlomit Reich-Zeliger, Oren Milstein, Sarit Aviel‐Ronen, Gideon Rechavi, Nir Friedman, Naftali Kaminski, JUSTEN H. PASSWELL et al. · 2002 · Nature Medicine
29. Costimulatory and coinhibitory receptors in anti‐tumor immunity
    Grégory Driessens, Justin Paul Kline, Thomas Frank Gajewski · 2009 · Immunological Reviews
30. An early history of T cell-mediated cytotoxicity
    Pierre Golstein, Gillian M. Griffiths · 2018 · Nature reviews. Immunology
31. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression
    N Nabavi, Gordon James Freeman, Andrea Gault, Dale Ian Godfrey, Lee Marshall Nadler, Laurie H. Glimcher · 1992 · Nature
32. CTLA4Ig: Bridging the Basic Immunology with Clinical Application
    Jeffrey A. Bluestone, E. William St. Clair, Laurence A. Turka · 2006 · Immunity
33. Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity
    Christian Potsch, David Voehringer, Hanspeter Pircher · 1999 · European Journal of Immunology
34. Mechanism of cellular rejection in transplantation
    Ingulli, Elizabeth · 2010 · Pediatric Nephrology
35. Advances in targeting cell surface signalling molecules for immune modulation
    Sheng Yao, Yuwen Zhu, Lieping Chen · 2013 · Nature Reviews Drug Discovery
36. Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma
    Ajay V. Maker, James Chih‐Hsin Yang, Richard Mark Sherry, Suzanne Louise Topalian, Udai S. Kammula, Richard Eldon Royal, Marybeth S. Hughes, Michael Jay Yellin, Leah R. Haworth, Catherine L. Levy et al. · 2006 · Journal of Immunotherapy
37. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
    James W. Young, Lydia Koulova, Steve A. Soergel, Edward A. Clark, Ralph M. Steinman, Bo Dupont · 1992 · Journal of Clinical Investigation
38. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
    Fiona Harding, James Patrick Allison · 1993 · The Journal of Experimental Medicine
39. Expression and functional significance of an additional ligand for CTLA-4.
    Deborah J. Lenschow, Gloria H. Su, L A Zuckerman, N Nabavi, C L Jellis, G S Gray, Jim Miller, Jeffrey A. Bluestone · 1993 · Proceedings of the National Academy of Sciences
40. CD80, CD86 and CD40 Provide Accessory Signals in a Multiple‐Step T‐Cell Activation Model
    Stefaan W. Van Gool, Peter Vandenberghe, Mark de Boer, Jan Louis Ceuppens · 1996 · Immunological Reviews
41. A Native Soluble Form of CTLA-4
    Martin K. Oaks, Karen M. Hallett, R.Todd Penwell, Edward C. Stauber, Simon Warren, Alfred J. Tector · 2000 · Cellular Immunology
42. Structural Analysis of CTLA-4 Function In Vivo
    Masteller, Emma L, Chuang, Ellen, Mullen, Alan C, Reiner, Steve L, Thompson, Craig B · 2000 · The Journal of Immunology
43. Basis of CTLA-4 function in regulatory and conventional CD4+ T cells
    Xuguang Tai, François Van Laethem, Leonid A. Pobezinsky, Terry I. Guinter, Susan O. Sharrow, Anthony Adams, Larry G. Granger, Michael J. Kruhlak, Tullia Lindsten, Craig B. Thompson et al. · 2012 · Blood
44. Dynamics and Requirements of T Cell Clonal Expansion In Vivo at the Single-Cell Level: Effector Function Is Linked to Proliferative Capacity
    Hrefna Guðmundsdóttir, Andrew D. Wells, Laurence A. Turka · 1999 · The Journal of Immunology
45. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Xuexiang Du, Fei Tang, Mingyue Liu, Juanjuan Su, Yan Zhang, Wei Wu, Martin Devenport, Christopher A. Lazarski, Peng Zhang, Xu Wang et al. · 2018 · Cell Research
46. Costimulation through B7-2 (CD86) Is Required for the Induction of a Lung Mucosal T Helper Cell 2 (TH2) Immune Response and Altered Airway Responsiveness
    Shogo Tsuyuki, Junko Tsuyuki, Karin Einsle, Manfred Köpf, Anthony J. Coyle · 1997 · The Journal of Experimental Medicine
47. Cutting Edge: A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models
    Dallas B. Flies, Shengdian Wang, Haiying Xu, Lieping Chen · 2011 · The Journal of Immunology
48. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Robert Peach, Jürgen Bajorath, William Brady, Gina Leytze, JoAnne L. Greene, Joseph R. Naemura, Peter S. Linsley · 1994 · The Journal of Experimental Medicine
49. Human B Lymphocytes: Phenotype, Proliferation, and Differentiation
    Jacques Banchereau, F Rousset · 1992 · Advances in immunology
50. Inhibitory Receptors Beyond T Cell Exhaustion
    Silvia A. Fuertes Marraco, Natalie J. Neubert, Grégory Verdeil, Daniel E. Speiser · 2015 · Frontiers in Immunology
51. Cardiotoxicity of immune checkpoint inhibitors
    Gilda Varricchi, Maria Rosaria Galdiero, Giancarlo Marone, Gjada Criscuolo, Maria Triassi, Domenico Bonaduce, Gianni Marone, Carlo Gabriele Tocchetti · 2017 · ESMO Open
52. Molecular and Cellular Functions of CTLA-4
    Samya Van Coillie, Bartosz Wiernicki, Jie Xu · 2020 · Advances in experimental medicine and biology
53. The role of CTLA‐4 in the regulation of T cell immune responses
    Kathy D. McCoy, Graham S Le Gros · 1999 · Immunology and Cell Biology
54. Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions
    JoAnne L. Greene, Gina Leytze, John Emswiler, Robert Peach, Jürgen Bajorath, Wesley L. Cosand, Peter S. Linsley · 1996 · Journal of Biological Chemistry
55. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes
    Brian J. Nickoloff, Laurence A. Turka · 1994 · Immunology Today
56. Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease
    Martin K. Oaks, Karen M. Hallett · 2000 · The Journal of Immunology
57. Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell Lymphoma
    Susmit Suvas, Vinod Singh, Sudhir Sahdev, Harpreet Vohra, Javed Naim Agrewala · 2002 · Journal of Biological Chemistry
58. Lipopolysaccharide interferes with the induction of peripheral T cell death
    Anthony T. Vella, James E. McCormack, Peter S. Linsley, John W. Kappler, Philippa Marrack · 1995 · Immunity
59. Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements.
    Michael Croft, David D. Duncan, Susan L. Swain · 1992 · The Journal of Experimental Medicine
60. Aberrant Regulation of Synovial T Cell Activation by Soluble Costimulatory Molecules in Rheumatoid Arthritis
    Bing Wan, Hong Nie, Ailian Liu, Guozhang Feng, Dongyi He, Rong Xu, Qi Zhang, Chen Dong, Jingwu Z. Zhang · 2006 · The Journal of Immunology
61. Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes
    Marco Antonio Moro‐García, Juan C. Mayo, Rosa María Sainz, Rebeca Alonso‐Arias · 2018 · Frontiers in Immunology
62. Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
    Katrin Klocke, Shimon Sakaguchi, Rikard Holmdahl, Kajsa Wing · 2016 · Proceedings of the National Academy of Sciences
63. Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
    Karl S. Peggs, Sergio A. Quezada, James Patrick Allison · 2008 · Immunological Reviews
64. A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
    Robert D. Leone, Ying-Chun Lo, Jonathan D. Powell · 2015 · Computational and Structural Biotechnology Journal
65. The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
    Alexandra Schnell, Lloyd Bod, Asaf Madi, Vijay Kumar Kuchroo · 2020 · Cell Research
66. Overcoming Immune Evasion in Melanoma
    Kevinn Eddy, Suzie Chen · 2020 · International Journal of Molecular Sciences
67. T‐cell costimulatory pathways in allograft rejection and tolerance
    David M. Rothstein, Mohamed H. Sayegh · 2003 · Immunological Reviews
68. 4‐1BB T‐cell antigen binds to mature B cells and macrophages, and costimulates anti‐μ‐primed splenic B cells
    Karen E. Pollok, Young‐June Kim, J Hurtado, Shang Zhen Zhou, K K Kim, Byoung Se Kwon · 1994 · European Journal of Immunology
69. Where excludability matters: Material versus intellectual property in academic biomedical research
    John P. Walsh, Wesley M. Cohen, Charlene Cho · 2007 · Research Policy
70. Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis
    Philip J. Mease, Alice Bendix Gottlieb, Désirée M F M van der Heijde, Oliver FitzGerald, Alyssa K. Johnsen, Marleen Nys, Subhashis Banerjee, Dafna D. Gladman · 2017 · Annals of the Rheumatic Diseases
71. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression
    Jianhua Gong, M Zhang, Robert L. Modlin, Peter S. Linsley, Dinakar Iyer, Yu-Pin Lin, Peter F. Barnes · 1996 · Infection and Immunity
72. Costimulation of T-cell growth
    Yang Liu, Peter S. Linsley · 1992 · Current Opinion in Immunology
73. Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responses
    Meenakshi Roy, Alejandro A. Aruffo, Jeffrey A. Ledbetter, Peter S. Linsley, Marilyn R. Kehry, Randolph J. Noelle · 1995 · European Journal of Immunology
74. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
    Alison M. Paterson, Scott B. Lovitch, Peter T. Sage, Vikram R. Juneja, Youjin Lee, Justin D. Trombley, Carolina V. Arancibia-Cárcamo, Raymond A. Sobel, Alexander Yu Rudensky, Vijay Kumar Kuchroo et al. · 2015 · The Journal of Experimental Medicine
75. The Impact of T Helper and T Regulatory Cells on the Regulation of Anti-Double-Stranded DNA B Cells
    Su-jean Seo, Michele L. Fields, Jodi L. Buckler, Amy J. Reed, Laura Mandik‐Nayak, Simone A. Nish, Randolph J. Noelle, Laurence A. Turka, Fred D. Finkelman, Andrew J. Caton et al. · 2002 · Immunity
76. Differential binding properties of B7-H1 and B7-DC to programmed death-1
    Pornpan Youngnak‐Piboonratanakit, Yuko Kozono, Haruo Kozono, Hideyuki Iwai, Noriko Otsuki, Hisayo Jin, Ken Omura, Hideo Yagita∥, Drew M. Pardoll, Lieping Chen et al. · 2003 · Biochemical and Biophysical Research Communications
77. The Role of CTLA‐4 in the Regulation and Initiation of T‐Cell Responses
    Cynthia A. Chambers, Matthew F. Krummel, Brigitte Boitel, A. A. Hurwitz, Tim J. Sullivan, Sylvie Fournier, Delanih Cassell, Monika Christine Brunner-Weinzierl, James Patrick Allison · 1996 · Immunological Reviews
78. Studies Using Antigen-Presenting Cells Lacking Expression of Both B7-1 (CD80) and B7-2 (CD86) Show Distinct Requirements for B7 Molecules During Priming Versus Restimulation of Th2 But Not Th1 Cytokine Production
    Alain Schweitzer, Arlene H. Sharpe · 1998 · The Journal of Immunology
79. Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo
    Muriel Moser, Thibaut De Smedt, Thierry Sornasse, Françoise Tielemans, Aziz Alami Chentoufi, Éric Muraille, Marcelle Van Mechelen, Jacques Urbain, Oberdan Léo · 1995 · European Journal of Immunology
80. Cellular and Molecular Characterization of the scurfy Mouse Mutant
    Lisa B. Clark, Mark W. Appleby, Mary E. Brunkow, John Erby Wilkinson, Steven F. Ziegler, Fred Ramsdell · 1999 · The Journal of Immunology
81. CD25+CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production
    Thomas Barthlott · 2005 · International Immunology
82. Control of Regulatory T Cell Migration, Function, and Homeostasis
    Daniel Campbell · 2015 · The Journal of Immunology
83. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production.
    Robert A. Seder, Ronald N. Germain, Peter S. Linsley, W E Paul · 1994 · The Journal of Experimental Medicine
84. The Role of CD80, CD86, and CTLA4 in Alloimmune Responses and the Induction of Long-Term Allograft Survival
    Thomas A. Judge, Zihou Wu, Xiang-Guang Zheng, Arlene H. Sharpe, Mohamed H. Sayegh, Laurence A. Turka · 1999 · The Journal of Immunology
85. Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
    Tsvetelina Pentcheva‐Hoang, Emily Corse, James Patrick Allison · 2009 · Immunological Reviews
86. Cutting Edge: Reversal of Murine Lupus Nephritis with CTLA4Ig and Cyclophosphamide
    David Daikh, David Wofsy · 2001 · The Journal of Immunology
87. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
    Vassiliki A. Boussiotis, Gordon James Freeman, John G. Gribben, J F Daley, G S Gray, Lee Marshall Nadler · 1993 · Proceedings of the National Academy of Sciences
88. T cell costimulation blockade blunts pressure overload-induced heart failure
    Marinos Kallikourdis, Elisa Martini, Pierluigi Carullo, Claudia Sardi, Giuliana Roselli, Carolina M. Greco, Debora Vignali, Federica Riva, Anne Marie Ormbostad Berre, Tomas Stølen et al. · 2017 · Nature Communications
89. Chronic Implant-Related Bone Infections—Can Immune Modulation be a Therapeutic Strategy?
    Elisabeth Seebach, Katharina F. Kubatzky · 2019 · Frontiers in Immunology
90. Costimulatory pathways in transplantation: challenges and new developments
    X.C. Li, David M. Rothstein, Mohamed H. Sayegh · 2009 · Immunological Reviews
91. The soluble CD40 ligand sCD154 in systemic lupus erythematosus
    Kazunori Kato, Ernesto Santana-Sahagún, Laura Z. Rassenti, Michael H. Weisman, Naoto Tamura, S Kobayashi, Hiroshi Hashimoto, Thomas J. Kipps · 1999 · Journal of Clinical Investigation
92. Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail
    Leung, Helios T., Bradshaw, Jeff, Cleaveland, Jeffrey S., Linsley, Peter S. · 1995 · Journal of Biological Chemistry
93. The Roles of IL-12 in Providing a Third Signal for Clonal Expansion of Naive CD8 T Cells
    Javier O. Valenzuela, Clint S. Schmidt, Matthew F. Mescher · 2002 · The Journal of Immunology
94. The role of B7 family molecules in hematologic malignancy
    Paul Greaves, John G. Gribben · 2012 · Blood
95. B7-1 Engagement of Cytotoxic T Lymphocyte Antigen 4 Inhibits T Cell Activation in the Absence of CD28
    Francesca Fallarino, Patrick E. Fields, Thomas Frank Gajewski · 1998 · The Journal of Experimental Medicine
96. Advances in antibody-based therapy in oncology
    Sacha Zinn, Rodrigo Vazquez-Lombardi, Carsten Zimmermann, Puja Sapra, Lutz Jermutus, Daniel Christ · 2023 · Nature Cancer
97. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
    Kajsa Wing, Tomoyuki Yamaguchi, Shimon Sakaguchi · 2011 · Trends in Immunology
98. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats
    Pascal Chaux, Nathalie Favre, Monique Martin, François Martin · 1997 · International Journal of Cancer
99. Immunology beats cancer: a blueprint for successful translation
    Drew M. Pardoll · 2012 · Nature Immunology
100. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice.
     Sylvie Guerder, Dominic Picarella, Peter S. Linsley, Richard Anthony Flavell · 1994 · Proceedings of the National Academy of Sciences